Clinical Trial Update: A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study comparing CellCept (mycophenolate mofetil) with mycophenolate sodium in kidney transplant recipients. The trial has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2014-10-10